Norbrook's Chemical Synthesis Division provides a unique service of contract synthesis from gram through to full-scale production to cGMP requirements, by an independent company committed to the highest standards of quality, service and efficiency. We are able to provide our clients with a full range of services such as process development from bench top to pilot plant scale, and validated technology transfer to full-scale bulk pharmaceutical manufacture. There are many benefits of using our services and facilities: - Outsourcing of non-core activities
- Speed of response and flexibility
- No need for capital investment
- Access to specialised facilities and services
- Savings due to cost effectiveness
- No compromise on quality.
Norbrook's investment in modern equipment and facilities offers a combination of capacity, flexibility and responsiveness to our customers' needs. The Norbrook's quality culture' has ensured that our facilities are approved by the world's most rigorous regulatory systems as well as by auditors of the major global healthcare companies. As a result, Norbrook lists many of the world's largest pharmaceutical companies among its prestigious client base. In the current climate of rationalisation and increasing demands on capital expenditure, Norbrook offers world class manufacturing facilities at very competitive costs and offers pharmaceutical companies a low cost, high quality alternative to investment in their own facilities. | 
